Impact of drug regulations and diversion control systems on legitimate narcolepsy patients.
作者信息
Piscopo J A
机构信息
National Commission on Sleep Disorders Research, American Narcolepsy Association, Inc., San Francisco, California 94104.
出版信息
NIDA Res Monogr. 1993;131:249-59.
PMID:8105384
Abstract
摘要
相似文献
1
Impact of drug regulations and diversion control systems on legitimate narcolepsy patients.
NIDA Res Monogr. 1993;131:249-59.
2
[Gammahydroxybutyrate must remain available for patients with narcolepsy].γ-羟基丁酸必须继续供应给发作性睡病患者。
Ned Tijdschr Geneeskd. 1999 Oct 9;143(41):2062-3.
3
[Effect of the new drug provisions on the drug treatment of narcolepsy].
Dtsch Med Wochenschr. 2004 May 21;129(21):1198-201. doi: 10.1055/s-2004-824871.
4
Summary and conclusions of a review of prescription drug diversion control methods.
NIDA Res Monogr. 1993;131:206-23.
5
Time to update Uniform Controlled Substances Act.
Wis Med J. 1997 May;96(5):8.
6
7
Diversion investigation units--methods, utilities, and limitations.
NIDA Res Monogr. 1993;131:145-50.
8
An American Medical Association perspective on preventing prescription drug diversion.
NIDA Res Monogr. 1993;131:224-7.
9
10
Consequences of the 1989 New York State triplicate benzodiazepine prescription regulations.1989年纽约州苯二氮䓬类药物三联处方规定的后果。
NIDA Res Monogr. 1993;131:279-93.
Zotero 插件